PRODRUGS OF THE SELECTIVE PROGESTERONE RECEPTOR MODULATOR (SPRM) (11.BETA.,17.BETA.)-17-HYDROXY-11-[4-(METHYLSULPHONYL)PHENYL]-17-(PENTAFLUOROETH YL)ESTRA-4,9-DIEN-3-ONE

The invention concerns Selective Progesterone Receptor Modulators (SPRM) in a prodrug form as well as their application in therapy. (3[alpha], 11[beta],17[beta])-1 1-[4-(methylsulfonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-diene-3,17-diol (Compound 1) is one of the invention prodrugs. 本发明涉及前药形式的选择性...

Full description

Saved in:
Bibliographic Details
Main Authors ROTTMANN ANTJE, MILITZER HANSRISTIAN, WAGENFELD ANDREA, IRLBACHER HORST
Format Patent
LanguageChinese
English
Published 09.11.2018
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
STEROIDS
Online AccessGet full text

Cover

More Information
Summary:The invention concerns Selective Progesterone Receptor Modulators (SPRM) in a prodrug form as well as their application in therapy. (3[alpha], 11[beta],17[beta])-1 1-[4-(methylsulfonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-diene-3,17-diol (Compound 1) is one of the invention prodrugs. 本发明涉及前药形式的选择性孕酮受体调节剂(SPRM)及其在治疗中的应用。(3α,11β,17β)-11-[4-(甲基磺酰基)苯基]-17-(五氟乙基)雌甾-4,9-二烯-3,17-二醇(化合物1)是本发明前药中的种。
Bibliography:Application Number: CN201780014127